To assess Pharmacokinetics, Safety and Tolerability of Ketoconazole with Abt-450/R, Ombitasvir and Dasabuvir in Healthy Adult Subjects.

Trial Profile

To assess Pharmacokinetics, Safety and Tolerability of Ketoconazole with Abt-450/R, Ombitasvir and Dasabuvir in Healthy Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Mar 2016

At a glance

  • Drugs Dasabuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Ketoconazole
  • Indications Hepatitis C
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 12 Mar 2016 Results assessing effect of ketoconazole on paritaprevir pharmacokinetics presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 07 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top